Literature DB >> 19141294

Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells.

Wenjie Xie1, Yongsheng Wang, Yafang Huang, Hongzhen Yang, Jiaping Wang, Zhuowei Hu.   

Abstract

MDA-MB-231 breast cancer cells have a high invasive potential, yet the mechanisms involved are not known. This study showed that Toll-like receptor 2 (TLR2) was highly expressed in MDA-MB-231 cells and played a critical role in cell invasion. Compared with the poorly invasive MCF-7 cells, MDA-MB-231 cells expressed 10.5-fold more TLR2. Using TLR2 agonist pg-LPS and TLR2 neutralizing antibody, we found that TLR2 activation significantly promoted MDA-MB-231 invasion, whereas TLR2 blockade diminished this capacity. TLR2 activation enhanced the activity of NF-kappaB and induced phosphorylation of TAK1 and IkappaBalpha in the TLR2/NF-kappaB signaling pathway in MDA-MB-231, but not in MCF-7 cells. TLR2 activation increased IL-6, TGF-beta, VEGF and MMP9 secretion, which are associated with TLR2-NF-kappaB signaling. We demonstrated that TLR2 is a critical receptor responsible for NF-kappaB signaling activity and highly invasive capacity of MDA-MB-231 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141294     DOI: 10.1016/j.bbrc.2009.01.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells.

Authors:  Fan Wang; Peng Zhang; Lang Yang; Xi Yu; Xianzhong Ye; Jing Yang; Cheng Qian; Xia Zhang; You-Hong Cui; Xiu-Wu Bian
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice.

Authors:  Jun Yan; Fang Hua; Han-zhi Liu; Hong-zheng Yang; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

4.  TLR2∆22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India.

Authors:  K Rekha Devi; Saia Chenkual; Gautam Majumdar; Jishan Ahmed; Tanvir Kaur; Jason C Zonunmawia; Kaustab Mukherjee; Rup Kumar Phukan; Jagdish Mahanta; S K Rajguru; Debdutta Mukherjee; Kanwar Narain
Journal:  Tumour Biol       Date:  2015-07-19

5.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

6.  Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Christine A Earle; Weiliang Xia
Journal:  Cytoskeleton (Hoboken)       Date:  2011-11-29

7.  Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Authors:  Huan Yang; Huiqin Zhou; Ping Feng; Xiaoni Zhou; Huiyan Wen; Xiaofang Xie; Haiying Shen; Xueming Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-10

8.  Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells.

Authors:  Jiong Jiang; Lei Dong; Bin Qin; Haitao Shi; Xiaoyan Guo; Yan Wang
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

9.  Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.

Authors:  Mohammad F Al-Harras; Maha E Houssen; Mohamed E Shaker; Kamel Farag; Omar Farouk; Rehan Monir; Rasha El-Mahdy; Ekbal M Abo-Hashem
Journal:  Oncol Lett       Date:  2016-01-28       Impact factor: 2.967

10.  Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.

Authors:  Yusuke Sato; Yasufumi Goto; Norihiko Narita; Dave S B Hoon
Journal:  Cancer Microenviron       Date:  2009-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.